Graduate School of Bioresources, Mie University, Mie 514-8507, Japan.
Mol Pharm. 2020 Jul 6;17(7):2672-2681. doi: 10.1021/acs.molpharmaceut.0c00364. Epub 2020 Jun 2.
Although iatrogenic ureteral injury and its lack of recognition due to ureteral invisibility are serious incidents in open and laparoscopic abdominal surgeries, there are currently no safe and effective methods for intraoperative ureteral identification (IUI) and diagnosis (IUD). In this study, I designed and chemically synthesized a near-infrared fluorescence (NIRF) imaging probe (CD-NIR-1) and evaluated its clearance and ability for IUI and IUD in animal models. CD-NIR-1 demonstrated high specificity and ultrarapid clearance by rat kidneys to the urinary bladder following intravenous administration of a single dose (25 nmol/kg of body weight), with 96% of the dose ultimately excreted at the first urination with no chemical modification. Furthermore, urine containing CD-NIR-1 in ureters showed strong NIRF, thereby enabling IUI and IUD via NIRF imaging. These results demonstrated the efficacy of CD-NIR-1 for clinical use.
尽管医源性输尿管损伤及其因输尿管不可见而导致的漏诊在开放和腹腔镜腹部手术中是严重的事件,但目前尚无安全有效的术中输尿管识别(IUI)和诊断(IUD)方法。在这项研究中,我设计并化学合成了一种近红外荧光(NIRF)成像探针(CD-NIR-1),并在动物模型中评估了其在 IUI 和 IUD 中的清除率和能力。CD-NIR-1 在单次静脉注射(25 nmol/kg 体重)后,通过大鼠肾脏对膀胱表现出高度的特异性和超快清除率,最终有 96%的剂量在首次排尿时排出,无需化学修饰。此外,含有 CD-NIR-1 的尿液在输尿管中显示出强烈的 NIRF,从而可以通过 NIRF 成像进行 IUI 和 IUD。这些结果表明 CD-NIR-1 具有临床应用的潜力。